Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 253-410-9 | CAS number: 37224-61-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
ORAL
- LD50 = 122 mg/kg, mouse (male), equivalent/similar to OECD 401, DeCrescente (1982)
- LD50 = 96 mg/kg, mouse (female), equivalent/similar to OECD 401, DeCrescente (1982)
- LD50 = 0.285 ± 0.005 cc/kg, rat (male), no guideline followed, Haag (1954)
DERMAL
- LD50 = in excess of 200 mg/kg, Section 191.10 of the Final Order, Enforcement Regulations, Federal Register, Vol. 26, No. 155, P. 7336, 12 August 1961, Shalanski & Moldovan (1969)
- LD50 = 1.33 ± 0.60 cc/kg, rabbit (male), no guideline followed, Haag (1954)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 96 mg/kg bw
- Quality of whole database:
- The quality of the database is considered to be sufficient; two studies have been assigned a reliability score of 2, whereas one study cannot be assigned a reliability score other than 4 as limited information on materials and methods is provided.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 200 mg/kg bw
- Quality of whole database:
- A high quality database is not available for this endpoint; it was not possible to assign either of the two available studies a reliability score other than 4 as limited information on materials and methods are provided. However the available data is sufficient to address this endpoint for this type of registration.
Additional information
Oral
This endpoint has been addressed with three studies in a weight of evidence approach.
The first study, DeCrescente (1982) investigated the acute oral toxicity of the test material in which groups of 10 male CD-1 mice were administered a suspension of test material in corn oil at 0 (vehicle control), 60, 75, 95, 119, or 150 mg/kg bw, orally, via gavage. The mice were observed over a period of 14 days for mortality and clinical signs; body weights were recorded at study initiation and again at termination (group average). All animals were subjected to gross necropsy at termination.
The study was conducted to sound scientific principles and so was assigned a reliability score of 2 in line with the principles for assessing data quality as defined by Klimisch et al. (1997).
Under the conditions of the study, the acute oral LD50 was determined to be 122 mg/kg to male CD-1 mice.
The second study, DeCrescente (1982) investigated the acute oral toxicity of the test material in a study in which groups of 10 female CD-1 mice were administered a suspension of test material in corn oil at 0 (vehicle control), 60, 75, 95, 119, or 150 mg/kg bw, orally, via gavage. The mice were observed over a period of 14 days for mortality and clinical signs; body weights were recorded at study initiation (group average) and at termination (in one animal). All animals were subjected to gross necropsy at termination. The study was conducted to sound scientific principles and so was assigned a reliability score of 2 in line with the principles for assessing data quality as defined by Klimisch et al. (1997).
Under the conditions of the study, the acute oral LD50 was determined to be 96 mg/kg to female CD-1 mice.
The third study, Haag (1954) contained limited information on materials and methods; it is therefore not possible to assess the reliability of the relevant results.
Groups of 10 fasted male rats were administered a suspension of test material in corn oil orally, by gavage, at doses of 0.25, 0.30 or 0.34 cc/kg. Mortality was recorded.
Under the conditions of the study, the LD50 of the test material to male rats was reported to be 0.285 ± 0.005 cc/kg.
Dermal
This endpoint has been addressed with two studies in a weight of evidence approach.
The first study, Shalanski & Moldovan (1969), was performed on 10 albino rabbits according to the method described under Section 191.10 of the Final Order, Enforcement Regulations, Federal Register, Vol. 26, No. 155, P. 7336, 12 August 1961.
During the study 10 rabbits received 200 mg/kg test material to a site of intact skin. None of the animals died during the study.
There is limited information on materials and methods within this study; it is therefore not possible to assess the reliability of the relevant results.
The acute dermal LD50 was therefore reported to be in excess of 200 mg/kg.
Although the LD50 value was determined to be above 200 mg/kg, it is not possible to determine that the LD50 value does not fall into Category 3 with the data that is available. Therefore this classification has been applied on a precautionary basis.
The second study, Haag (1954) contains limited information on materials and methods within this study; it is therefore not possible to assess the reliability of the relevant results.
Within this study, Groups of young male rabbits were clipped free of hair and topically administered test material at 0.5, 1.0, 1.5, 2.0, 2.5, or 3.0 and above cc/kg. Mortality was recorded.
Under the conditions of the study, the LD50 of the test material was reported to be 1.33 ± 0.60 cc/kg.
Justification for selection of acute toxicity – oral endpoint
No study has been selected as key; this endpoint has been addressed via a weight of evidence approach using three studies.
Justification for selection of acute toxicity – dermal endpoint
No study has been selected as key; this endpoint has been addressed via a weight of evidence approach using two studies.
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No. 1272/2008, substance requires classification with respect to acute (oral) toxicity as Category 3 (H301: Toxic if swallowed).
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No. 1272/2008, substance requires classification with respect to acute (dermal) toxicity as Category 3 (H311: Toxic in contact with skin).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.